Market Place
Sourcing Support
Teva`s 2025 Report Highlights Environmental, Access Gains
30 Apr 2026 //
ACCESSWIRE
In Lilly patent spat, appeals court revives $177M verdict to Teva
17 Apr 2026 //
FIERCE PHARMA
Community Routes Secures Funding For Mental Health Services
14 Apr 2026 //
GLOBENEWSWIRE
Teva To Discuss Q1 2026 Financial Results In Conference Call
19 Mar 2026 //
GLOBENEWSWIRE
Teva Releases Q1 2026 Aide Memoire
19 Mar 2026 //
GLOBENEWSWIRE
EU Court Rejects Industry Bid to Annul Wastewater Directive
26 Feb 2026 //
RAPS
Teva To Present At The Upcoming Investor Conferences In March
24 Feb 2026 //
GLOBENEWSWIRE
Corcept Provides Update on Patent Dispute with Teva Pharma
19 Feb 2026 //
BUSINESSWIRE
Medimpact Introduces Humira Biosimilar At 95% Discount
10 Feb 2026 //
BUSINESSWIRE
Teva`s Pivot Drives Third Year of Consecutive Growth
28 Jan 2026 //
GLOBENEWSWIRE
JPM26: What`s In A Biopharma? CEO Says Teva Has The Goods
16 Jan 2026 //
FIERCE PHARMA
Teva Showcases Growth Strategy At J.P. Morgan Healthcare Conf
11 Jan 2026 //
GLOBENEWSWIRE
Teva, Royalty Pharma Partner To Fast-Track Vitiligo Treatment
11 Jan 2026 //
GLOBENEWSWIRE
Teva To Present At 44Th J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
S&P Upgrades Teva to BB+; Moody`s Outlook Positive
24 Dec 2025 //
GLOBENEWSWIRE
Teva To Host Conference Call On Q4 2025 Financial Results On Jan
12 Dec 2025 //
GLOBENEWSWIRE
Teva Releases Q4 2025 Aide Memoire
12 Dec 2025 //
GLOBENEWSWIRE
How one company’s focus on the patient journey fuels innovation
08 Dec 2025 //
FIERCE PHARMA
Teva To Present At Multiple Healthcare Conferences In December
21 Nov 2025 //
GLOBENEWSWIRE
Teva Debuts Innovation Platform To Parry Key Industry Challenges
19 Nov 2025 //
FIERCE PHARMA
Teva`s Austedo Shows Real-World Benefits In Tardive Dyskinesia
07 Nov 2025 //
GLOBENEWSWIRE
Teva Reports 11th Consecutive Quarter Of Growth
06 Nov 2025 //
INDPHARMAPOST
Teva`s Innovative Portfolio Drives Quarter of Growth in Q3 2025
05 Nov 2025 //
GLOBENEWSWIRE
Teva CEO Touts `Defining Strength` Of Innovative Drugs
05 Nov 2025 //
FIERCE PHARMA
Teva Drafts Terrell Davis For Tardive Dyskinesia Awareness Drive
05 Nov 2025 //
FIERCE PHARMA
Teva To Present at UBS & Jefferies Healthcare Conferences
31 Oct 2025 //
GLOBENEWSWIRE
Teva Releases Q3 2025 Aide Memoire
25 Sep 2025 //
GLOBENEWSWIRE
Teva To Discuss Q3 2025 Financial Results In Conference Call
25 Sep 2025 //
GLOBENEWSWIRE
Teva And Medincell`s Risperidone Lai Receives Health Canada
23 Sep 2025 //
PHARMAWEB
Teva Reveals Promising SOLARIS Results for Olanzapine LAI
23 Sep 2025 //
INDPHARMAPOST
Medincell, Teva to Host Investor Call on Phase 3 Olanzapine LAI
17 Sep 2025 //
PHARMAWEB
Teva to Release Ph 3 SOLARIS Olanzapine LAI Data Sep 22, 2025
16 Sep 2025 //
GLOBENEWSWIRE
Colorado to Face Teva`s Lawsuit Over Allergy Pen Law
05 Sep 2025 //
REUTERS
Teva to Present at September Healthcare Conferences
02 Sep 2025 //
GLOBENEWSWIRE
FDA Approves Teva`s Ajovy for Migraine Prevention in Children
06 Aug 2025 //
REUTERS
Teva Execs Unfazed by New Pharmaceutical Tariffs
30 Jul 2025 //
FIERCE PHARMA
Teva`s Q2 2025 Growth Streak Continues; Ups 2025 Revenue Forecast
30 Jul 2025 //
GLOBENEWSWIRE
Teva Releases Q2 2025 Aide Memoire
26 Jun 2025 //
GLOBENEWSWIRE
Teva Conference Call on Q2 2025 Results on July 30
25 Jun 2025 //
GLOBENEWSWIRE
Teva and Fosun Pharma Partner to Develop Anti-PD1-IL2 Therapy
16 Jun 2025 //
GLOBENEWSWIRE
Teva 2024 Report: Health System Strengthening & Capacity Building
06 Jun 2025 //
ACCESSWIRE
Teva Announces Early Tender Results and Raises Tender Pool Cap
03 Jun 2025 //
GLOBENEWSWIRE
Teva Announces Pricing and Early Acceptance of Debt Tender Offer
03 Jun 2025 //
GLOBENEWSWIRE
Teva Shares Uzedy, TEV-‘749 Data In Schizophrenia At ASCO
30 May 2025 //
GLOBENEWSWIRE
Teva Data Shows Undertreated Tardive Dyskinesia at Psych Congress
30 May 2025 //
GLOBENEWSWIRE
Teva Reaffirms "pivot to Growth" Strategy with 2025 Launch
29 May 2025 //
GLOBENEWSWIRE
Teva to Present at Healthcare Conferences in June
27 May 2025 //
GLOBENEWSWIRE
Teva Increases Maximum Tender Amount and Pool Caps for Debt Offer
22 May 2025 //
GLOBENEWSWIRE
Fitch Upgrades Teva Rating to BB+ for Successful Growth Strategy
20 May 2025 //
GLOBENEWSWIRE
Teva Upsizes and Prices $2.3B Senior Notes to Repay Debt
20 May 2025 //
GLOBENEWSWIRE
Teva Launches $2B Senior Notes Offering
19 May 2025 //
GLOBENEWSWIRE
Teva Announces $2B Debt Tender Offers For Notes Due 2026-2031
19 May 2025 //
GLOBENEWSWIRE
Moody`s Investor Upgrades Teva Amid Success of Growth Strategy
15 May 2025 //
GLOBENEWSWIRE
Teva`s 2024 Healthy Future Report Highlights Sustainability Program
13 May 2025 //
ACCESSWIRE
Teva 2024 Report Shows Progress on Sustainability Goals
12 May 2025 //
GLOBENEWSWIRE
Teva to Host Innovation & Strategy Day on May 29 in New York City
07 May 2025 //
GLOBENEWSWIRE
Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025
07 May 2025 //
GLOBENEWSWIRE
US Court rules in favor of FDA, Salix, Teva, against Norwich
17 Apr 2025 //
ACCESSWIRE
Actavis to Slash 200 Workers as Teva’s Consolidation Efforts
08 Apr 2025 //
BIOSPACE
Teva to Discuss Q1 2025 Financial Results on May 7, 2025
27 Mar 2025 //
GLOBENEWSWIRE
